Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 17/20 | 0.57 |
| ▸ | DDB1 | Q16531 | 16/20 | 0.57 |
| ▸ | IKZF3 | Q9UKT9 | 2/20 | 0.43 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25036211 | 0.85 | DDB1 (0.53) | CRBNDDB1OPRM1OPRL1 | |
| SCHEMBL20845888 | 0.84 | CRBN (0.72) | CRBNDDB1IKZF3OPRM1ALDH1A1 | |
| SCHEMBL25036213 | 0.80 | CRBN (0.66) | CRBNDDB1IKZF3OPRM1ALDH1A1 | |
| SCHEMBL27452843 | 0.79 | CRBN (0.45) | CRBNDDB1IKZF3OPRM1ALDH1A1 | |
| SCHEMBL23540197 | 0.79 | DDB1 (0.55) | CRBNDDB1IKZF3 | |
| SCHEMBL25036235 | 0.78 | DDB1 (0.55) | CRBNDDB1OPRM1 | |
| SCHEMBL23540165 | 0.77 | DDB1 (0.56) | CRBNDDB1 | |
| SCHEMBL23540460 | 0.77 | DDB1 (0.56) | CRBNDDB1 | |
| SCHEMBL23540806 | 0.77 | DDB1 (0.56) | CRBNDDB1 | |
| Hydrochloric Acid SCHEMBL30258255 | 0.76 | DDB1 (0.56) | CRBNDDB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023019166-A1 | PROTEIN TYROSINE PHOSPHATASE TARGETING LIGANDS | CALICO LIFE SCIENCES LLC (US) | 2023-02-16 | — | — | WO | disclosed |